URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Babak Jahromi

Concepts (252)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Subarachnoid Hemorrhage
10
2003
28
2.800
Why?
Stroke
7
2006
117
2.320
Why?
Carotid Stenosis
4
2008
49
2.310
Why?
Vasospasm, Intracranial
9
2002
10
2.190
Why?
Stents
6
2008
123
1.900
Why?
Basilar Artery
9
2001
9
1.750
Why?
Cerebral Angiography
8
2002
56
1.480
Why?
Carotid Arteries
3
2008
106
1.460
Why?
Muscle, Smooth, Vascular
4
2001
377
1.310
Why?
Balloon Occlusion
2
2008
7
0.860
Why?
Endarterectomy, Carotid
3
2003
29
0.800
Why?
Carotid Artery Diseases
3
2003
59
0.800
Why?
Intracranial Aneurysm
2
2004
22
0.780
Why?
Perfusion Imaging
1
2010
12
0.760
Why?
Blood Vessel Prosthesis
1
2010
31
0.750
Why?
Dogs
10
2001
488
0.750
Why?
Calcium
6
1992
1127
0.740
Why?
Evidence-Based Medicine
1
2011
199
0.690
Why?
Hemostatic Techniques
1
2009
11
0.690
Why?
Subclavian Artery
1
2009
26
0.680
Why?
Myocytes, Smooth Muscle
2
2006
110
0.670
Why?
Large-Conductance Calcium-Activated Potassium Channels
2
2004
9
0.670
Why?
Neurosurgical Procedures
2
2004
46
0.670
Why?
Thromboembolism
1
2009
44
0.670
Why?
Catheters, Indwelling
1
2009
70
0.650
Why?
Embolization, Therapeutic
1
2008
40
0.650
Why?
Patch-Clamp Techniques
7
1999
159
0.640
Why?
Catheterization, Central Venous
1
2009
59
0.640
Why?
Vasoconstriction
1
2008
42
0.640
Why?
Shab Potassium Channels
1
2007
2
0.630
Why?
Vascular Surgical Procedures
1
2008
68
0.630
Why?
Muscle Cells
1
2007
11
0.620
Why?
Potassium
2
2006
306
0.610
Why?
Tomography, X-Ray Computed
3
2004
765
0.610
Why?
Potassium Channels
2
2004
130
0.600
Why?
Physician's Practice Patterns
1
2010
253
0.600
Why?
Clinical Trials as Topic
1
2011
675
0.600
Why?
Hemorrhage
1
2009
181
0.600
Why?
Thrombosis
1
2008
199
0.570
Why?
Postoperative Complications
1
2010
743
0.530
Why?
Time Factors
10
1999
3201
0.520
Why?
Aged, 80 and over
7
2003
2513
0.480
Why?
Chlamydophila pneumoniae
1
2003
9
0.480
Why?
Chlamydia Infections
1
2003
22
0.470
Why?
Treatment Outcome
6
2008
2623
0.440
Why?
Aged
9
2003
7272
0.420
Why?
Hemoglobins
2
2001
94
0.410
Why?
Membrane Potentials
4
1999
343
0.400
Why?
Peroxides
1
2001
17
0.390
Why?
Phosphatidylcholines
1
2001
63
0.390
Why?
Middle Aged
10
2003
9877
0.380
Why?
Nervous System Diseases
2
2011
147
0.370
Why?
Disease Models, Animal
7
2003
973
0.360
Why?
Pyramidal Cells
1
1999
26
0.330
Why?
Humans
18
2001
36400
0.330
Why?
Animals
17
1992
16270
0.320
Why?
Risk Assessment
3
2010
878
0.310
Why?
Intracellular Membranes
2
1992
76
0.300
Why?
Action Potentials
1
1999
256
0.300
Why?
Schwann Cells
2
1992
43
0.290
Why?
Male
11
1999
19713
0.260
Why?
Potassium Channels, Inwardly Rectifying
2
2004
23
0.260
Why?
Cohort Studies
2
2003
969
0.240
Why?
Brain
3
1999
1221
0.220
Why?
Female
12
2002
19826
0.220
Why?
Nitric Oxide Donors
2
2002
22
0.220
Why?
Neurotransmitter Agents
1
1992
46
0.210
Why?
Muscle, Smooth
3
2006
118
0.210
Why?
Neurosciences
1
2012
7
0.210
Why?
Carotid Artery Thrombosis
2
2008
10
0.210
Why?
Specialization
1
2012
42
0.200
Why?
Electric Stimulation
2
1992
228
0.200
Why?
STAT3 Transcription Factor
1
2011
37
0.200
Why?
Critical Care
1
2012
69
0.200
Why?
Follow-Up Studies
2
2003
1857
0.190
Why?
Synapses
1
1992
110
0.190
Why?
Meningeal Neoplasms
1
2011
51
0.190
Why?
Meningioma
1
2011
54
0.190
Why?
Kinetics
2
1999
1464
0.190
Why?
Markov Chains
1
2010
36
0.190
Why?
Health Resources
1
2010
15
0.190
Why?
Neurology
1
2012
91
0.190
Why?
Cell Proliferation
2
2008
521
0.180
Why?
Hospital Costs
1
2010
33
0.180
Why?
Inpatients
1
2010
69
0.180
Why?
RNA, Messenger
5
2004
1857
0.180
Why?
Cost-Benefit Analysis
1
2010
209
0.180
Why?
Angiography, Digital Subtraction
1
2009
19
0.170
Why?
Thrombolytic Therapy
2
2006
64
0.170
Why?
Cerebral Revascularization
1
2009
3
0.170
Why?
Organ Culture Techniques
2
2006
98
0.170
Why?
Punctures
1
2009
25
0.170
Why?
Device Removal
1
2009
31
0.170
Why?
Intracranial Embolism
1
2009
7
0.170
Why?
Radiography, Interventional
1
2009
27
0.170
Why?
Magnetic Resonance Angiography
1
2009
36
0.170
Why?
Aorta, Thoracic
1
2009
72
0.160
Why?
RNA, Ribosomal, 18S
1
2008
4
0.160
Why?
Glyceraldehyde-3-Phosphate Dehydrogenases
1
2008
14
0.160
Why?
Survival Rate
1
2010
619
0.160
Why?
Fatal Outcome
1
2008
109
0.160
Why?
Decompression, Surgical
1
2008
37
0.160
Why?
Prevalence
1
2010
541
0.160
Why?
Electric Conductivity
1
2008
89
0.160
Why?
Cells, Cultured
2
2001
2563
0.160
Why?
Catheterization
1
2009
127
0.160
Why?
Survival Analysis
1
2010
598
0.160
Why?
Feasibility Studies
1
2008
205
0.160
Why?
Diffusion Magnetic Resonance Imaging
1
2009
67
0.160
Why?
Reoperation
1
2008
186
0.160
Why?
Heparin
1
2009
125
0.160
Why?
Prostheses and Implants
1
2008
87
0.160
Why?
Random Allocation
1
2008
254
0.160
Why?
Dose-Response Relationship, Radiation
1
2008
218
0.150
Why?
Models, Cardiovascular
1
2008
70
0.150
Why?
Blotting, Western
2
2004
668
0.150
Why?
Angioplasty, Balloon
1
2008
72
0.150
Why?
Anticoagulants
1
2009
135
0.150
Why?
Endothelin-1
1
2007
24
0.150
Why?
Immunohistochemistry
2
2006
1063
0.150
Why?
Actins
1
2008
213
0.140
Why?
Risk Factors
2
2010
2318
0.140
Why?
Micromanipulation
1
2006
17
0.140
Why?
Isometric Contraction
1
2006
47
0.140
Why?
Infarction, Middle Cerebral Artery
1
2006
16
0.140
Why?
Cyclic GMP
2
2002
75
0.140
Why?
Transducers
1
2006
42
0.140
Why?
Tissue Plasminogen Activator
1
2006
51
0.130
Why?
United States
2
2010
2630
0.130
Why?
Fibrinolytic Agents
1
2006
57
0.130
Why?
Neuromuscular Junction
2
1992
38
0.130
Why?
Gene Expression Regulation
2
2007
875
0.130
Why?
Retrospective Studies
2
2008
2260
0.130
Why?
Adult
6
2002
11345
0.130
Why?
Calcium Channels
1
2006
167
0.130
Why?
Intracranial Thrombosis
1
2004
3
0.130
Why?
Aneurysm, Dissecting
1
2004
17
0.120
Why?
Intracranial Arteriovenous Malformations
1
2004
15
0.120
Why?
Jugular Veins
1
2004
25
0.120
Why?
Magnesium Sulfate
1
2004
11
0.120
Why?
Carotid Artery, Common
1
2004
35
0.120
Why?
Potassium Channels, Voltage-Gated
1
2004
37
0.120
Why?
Triazenes
1
2003
2
0.110
Why?
Blood Vessels
1
2004
91
0.110
Why?
Ion Channels
1
2004
154
0.110
Why?
Protein S Deficiency
1
2002
5
0.110
Why?
Nitroprusside
1
2002
32
0.110
Why?
Neuroprotective Agents
1
2004
125
0.110
Why?
Central Nervous System Vascular Malformations
1
2002
6
0.110
Why?
Craniotomy
1
2002
18
0.110
Why?
Astrocytoma
1
2002
30
0.110
Why?
Magnetic Resonance Imaging
1
2008
1010
0.110
Why?
Inferior Colliculi
1
2002
32
0.110
Why?
Cyclic AMP
1
2003
242
0.100
Why?
Predictive Value of Tests
1
2003
601
0.100
Why?
Dose-Response Relationship, Drug
2
2001
1138
0.100
Why?
Osmolar Concentration
1
2001
157
0.100
Why?
Buffers
1
1999
36
0.080
Why?
Brain Neoplasms
1
2002
282
0.080
Why?
Angioplasty
2
2009
30
0.080
Why?
Macaca fascicularis
3
2002
83
0.080
Why?
Egtazic Acid
1
1999
57
0.080
Why?
Chelating Agents
1
1999
67
0.080
Why?
Dendrites
1
1999
47
0.080
Why?
Coloring Agents
1
1999
56
0.080
Why?
Rats, Wistar
1
1999
166
0.080
Why?
Muscarinic Antagonists
1
1997
13
0.080
Why?
Receptors, Muscarinic
1
1997
33
0.080
Why?
Acetylcholine
1
1997
72
0.080
Why?
Rana pipiens
2
1992
19
0.070
Why?
Barium
2
2006
16
0.070
Why?
Coronary Vasospasm
2
2004
8
0.070
Why?
Young Adult
2
2009
1074
0.070
Why?
Rats
2
1999
4386
0.060
Why?
Blood Pressure
2
2004
474
0.050
Why?
MAP Kinase Kinase 2
1
2011
5
0.050
Why?
Inhibitor of Apoptosis Proteins
1
2011
9
0.050
Why?
MAP Kinase Kinase 1
1
2011
22
0.050
Why?
TOR Serine-Threonine Kinases
1
2011
30
0.050
Why?
Proto-Oncogene Proteins c-sis
1
2011
21
0.050
Why?
Retinoblastoma Protein
1
2011
35
0.050
Why?
Caspase 3
1
2011
93
0.050
Why?
Mitogen-Activated Protein Kinase 3
1
2011
106
0.050
Why?
Platelet-Derived Growth Factor
1
2011
115
0.050
Why?
Immunoblotting
1
2011
222
0.050
Why?
Health Surveys
1
2012
198
0.050
Why?
Mitogen-Activated Protein Kinase 1
1
2011
106
0.050
Why?
Proto-Oncogene Proteins c-akt
1
2011
134
0.050
Why?
Adolescent
2
2009
4752
0.050
Why?
Databases as Topic
1
2010
35
0.050
Why?
DNA Replication
1
2011
197
0.050
Why?
Severity of Illness Index
2
2003
919
0.040
Why?
Thrombectomy
1
2009
15
0.040
Why?
Chi-Square Distribution
1
2010
333
0.040
Why?
Odds Ratio
1
2010
304
0.040
Why?
Length of Stay
1
2010
280
0.040
Why?
Intraoperative Complications
1
2009
57
0.040
Why?
Carotid Artery, Internal
1
2008
31
0.040
Why?
Disease Management
1
2008
26
0.040
Why?
Phosphorylation
1
2011
833
0.040
Why?
Connective Tissue
1
2008
43
0.040
Why?
Proliferating Cell Nuclear Antigen
1
2008
47
0.040
Why?
Tunica Media
1
2008
30
0.040
Why?
Blood Flow Velocity
1
2008
133
0.040
Why?
Logistic Models
1
2010
578
0.040
Why?
TRPC Cation Channels
1
2007
4
0.040
Why?
Indoles
1
2008
104
0.040
Why?
Angiography
1
2007
93
0.040
Why?
Antibodies, Monoclonal
1
2011
732
0.040
Why?
Age Factors
1
2010
1121
0.040
Why?
Electrophysiology
1
2007
247
0.040
Why?
Infusions, Intra-Arterial
1
2006
13
0.030
Why?
Equipment Failure Analysis
1
2006
73
0.030
Why?
Infusions, Intravenous
1
2006
139
0.030
Why?
Equipment Design
1
2006
247
0.030
Why?
Stress, Mechanical
1
2006
235
0.030
Why?
Echoencephalography
1
2004
8
0.030
Why?
Ultrasonography, Doppler, Transcranial
1
2004
11
0.030
Why?
Single-Blind Method
1
2004
118
0.030
Why?
Arteriovenous Shunt, Surgical
1
2004
17
0.030
Why?
Delayed Rectifier Potassium Channels
1
2004
10
0.030
Why?
Potassium Channels, Calcium-Activated
1
2004
12
0.030
Why?
Gene Targeting
1
2004
69
0.030
Why?
Sensitivity and Specificity
1
2007
905
0.030
Why?
Calcium Channels, L-Type
1
2004
49
0.030
Why?
Amino Acid Sequence
1
2007
1231
0.030
Why?
Regional Blood Flow
1
2004
190
0.030
Why?
Middle Cerebral Artery
1
2003
7
0.030
Why?
Cisterna Magna
1
2002
4
0.030
Why?
Injections
1
2002
67
0.030
Why?
Base Sequence
1
2007
1704
0.030
Why?
Cerebral Arteries
1
2002
40
0.030
Why?
Treatment Failure
1
2002
130
0.030
Why?
Signal Transduction
1
2011
1626
0.030
Why?
Up-Regulation
1
2004
372
0.030
Why?
Molecular Sequence Data
1
2007
2028
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
543
0.020
Why?
Rats, Sprague-Dawley
1
2004
1028
0.020
Why?
Prospective Studies
1
2004
1677
0.020
Why?
Muscarine
1
1997
3
0.020
Why?
Nicotinic Antagonists
1
1997
5
0.020
Why?
Gallamine Triethiodide
1
1997
5
0.020
Why?
Xanthenes
1
1997
12
0.020
Why?
Aniline Compounds
1
1997
24
0.020
Why?
Muscarinic Agonists
1
1997
21
0.020
Why?
Nicotinic Agonists
1
1997
10
0.020
Why?
Pertussis Toxin
1
1997
53
0.020
Why?
Virulence Factors, Bordetella
1
1997
55
0.020
Why?
Nicotine
1
1997
32
0.020
Why?
Adenosine
1
1997
91
0.020
Why?
Fluorescent Dyes
1
1997
232
0.020
Why?
Microscopy, Fluorescence
1
1997
277
0.020
Why?

Visualizations


Jahromi's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department